Evidence for the nutrtional benefits of bioactives is steadily accumulating, and the time has come engage regulators in a process of determining dietary reference intakes (DRIs) for the best-researched substances, said Jim Griffiths, vice president of scientific and reglatory affairs for the Council for Responsible Nutrition.
Breast cancer patients with high levels of vitamin D in their blood are twice as likely to survive the disease as those with lower levels, new research has suggested.
The makeup of microbes living in our gut may be a risk factor for colorectal cancer and could drive the development of intestinal tumours, say researchers.
Biomimicry, or the practice of taking cues from nature for design of products for human use, could transform the way dietary supplments manufacturers interact with their consumers, an expert says.
The final report from a government task force finding no preventive effect of multivitamin usage in relation to cancer and cardiovascular disease has been modified in an appropriate way to reflect the tight focus of the review, said the Council for Responsible Nutrition. How the report will be written about in the mainstream press remains to be seen.
Influential figures in the herbal sphere aren’t always involved in what most would term “natural” products. So it is with Gordon M Cragg, PhD, the latest recepient of a prominent award from the American Botanical Council.
Biothera, a company long known for an extensive research program backing both its nutraceutical and pharmaceutical ingredients derived from bakers yeast, has completed a mode of action study on its Wellmune dietary supplement ingedient.
MegaFood, a leading manufacurer of whole food supplements, has teamed up with an organic orange juice supplier for a ‘grove to tablet’ line of vitamin C supplements.
The Federal Trade Commission has filed a long awaited brief in POM Wonderful’s appeal of a false advertising case against the company. As expected, FTC contends that POM’s ads were deceptive, and the company lacked sufficient clinical data to back up its far-reaching claims on its products and that First Amendment protections do not apply.
Once again, negative results from a tightly focused study with a nutraceutical ingredient have been generalized in the mainstream media as a blanket condemnation. In this case, it was the news that megadoses of vitamin E fed to cancer-prone mice caused their tumors to grow faster. Despite the hubbub, it’s news that is, as far as human supplementation is concerned, “irrelevant,” said Duffy MacKay of the Council for Responsible Nutrition.
A paradigm shift is needed in the study of polyphenols to better understand the bioavailability, bio-activity, and the role of the gut microbiota in polyphenol metabolism and health benefits, say experts from academia and industry.
Bioavailability has always been the achilles heel of polyphenols. Scientist felt they had a good handle on why these molecules exerted their health effects, but had a far less clear view of how to get them to the locations in the body where they could do the most good. The answer for many years was a practice of putting in overages in formulations, an approach that was not very tidy, and potentially more expensive than it needed to be.
Tea polyphenols are poised to enjoy strong growth over the next decade, with a new market report calling for the global market in the ingredients to hit $368 million by 2020. That makes sense to observers, who say the popularity of tea, green tea in particular, boosts awareness of the ingredients derived from the plant.
With surging interest in the potential health benefits of polyphenols around the globe, experts suggest that there are still some major sticking points in the polyphenol success story.
Vitamin D could play a vital role in the regulation of cardiovascular function - and the risk of several disease states - by controlling arterial stiffness and levels of nitric oxide, according to new research in mice.
A patent-pending blend of compounds from kava with none of the potentially adverse liver effects may see the much-maligned herb re-emerge in the dietary supplement space, say researchers from the University of Minnesota.
The American Herbal Products Association (AHPA) is planning for 2014 with the assumption that the hot button issues for the New Year are likely to include three of the same subjects that demanded our attention in 2013: cGMP compliance, GMO labeling, and an aggressive media that misinforms consumers about supplements.
Many large clinical trials of vitamin supplements, including those concluding vitamins are of no value or may even be harmful, have a flawed methodologies that means they are 'useless' in determining the real value of such micronutrients, according to a new analysis.
These are confusing times to be a dietary supplement consumer – one day, a particular nutrient is touted as a magic bullet, and the next it’s a waste of money. In this constant news cycle we live in, consumers are left even more puzzled about what’s really good for them. As the year comes to a close, it’s worth examining three of the major dietary supplement health stories in the press that targeted some of the industry’s most popular products and led to consumer whiplash.
The coming year will see renewed challenges for the omega-3s sector, an industry leader said. Among the challenges will be new attacks from the medical community as well as a continuing depression of the US market as a consequence of the publication of a negative study connected to prostate cancer risk.
Natac, the expert in olive and grape ingredients, reviews the beneficial effects of the different bioactive compounds present in the g...
INNOBIO® Astaxanthin is naturally sourced from Haematococcus pluvialis. INNOBIO offers a variety of astaxanthin products ma...
NMI found that 35% of U.S. shoppers say non-GMO is a concern to them. That’s up from 25% two years ago. In this webinar you will learn...